BCL2L1 and malignant pleural mesothelioma: A recent study firstly showed that inhibiting Bcl-xL promotes mitochondrial outer membrane permeabilization (MOMP) in response to irradiation and lead to potent radiosensitization of malignant pleural mesothelioma (MPM) cells by Bcl-xL inhibitor A1331852 (41).